Stem Cells in Regenerative Medicine
Science, Regulation and Business Strategies
Stem cells, as therapeutic agents or as research or diagnostics tools, represent an emerging technology with a transformational potential that parallels the paradigm shift operated by the development of monoclonal antibodies in the 1990s, or even the coming of age of genetic engineering technology platforms in the 1980s. Those working with stem cell technologies face a complex matrix of ethical, regulatory, policy, logistics, supply chain, manufacturing, pricing and reimbursement challenges.This book is a unique guide to emerging stem cell technologies and the opportunities for their commercialisation. It provides in-depth analyses of the sci…
Mehr
CHF 205.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V105:
Folgt in ca. 15 Arbeitstagen
Produktdetails
Weitere Autoren: Qureshi, Nasib (Hrsg.) / Caplan, Arnold I. (Hrsg.) / Babiss, Lee E. (Hrsg.)
- ISBN: 978-1-119-97139-9
- EAN: 9781119971399
- Produktnummer: 17390944
- Verlag: John Wiley and Sons Ltd
- Sprache: Englisch
- Erscheinungsjahr: 2015
- Seitenangabe: 776 S.
- Masse: H20.2 cm x B25.7 cm x D4.0 cm 1'470 g
- Gewicht: 1470
- Sonstiges: Professional & Vocational
Über den Autor
Alain A. Vertès, London Business School, London, UKNasib Qureshi, United States Department of Agriculture (ARS), National Center for AgriculturalUtilization Research, Illinois, USAArnold I. Caplan, Case Western Reserve University, Ohio, USALee Babiss, Pharmaceutical Product Development, North Carolina, USA
7 weitere Werke von Alain A. (Hrsg.) Vertes:
Bewertungen
Anmelden